Advances in neurometabolic therapy
Actovegin is a calf blood extract that contains more than 200 biologically active compounds. Experiments have shown that Actovegin reduces the neurotoxic effect of amyloid, neutralizes reactive oxygen species, and normalizes the endothelial function of small vessels. The drug has not been shown to s...
Main Authors: | V. V. Zakharov, N. V. Vakhnina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2019-11-01
|
Series: | Nevrologiâ, Nejropsihiatriâ, Psihosomatika |
Subjects: | |
Online Access: | https://nnp.ima-press.net/nnp/article/view/1187 |
Similar Items
-
TREATMENT OF COGNITIVE IMPAIRMENT AFTER STROKE
by: V. V. Zakharov, et al.
Published: (2018-02-01) -
Modern View on the Pathogenetic Therapy of Diabetic Polyneuropathy
by: N.O. Pertseva, et al.
Published: (2014-10-01) -
A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design
by: Alla Guekht, et al.
Published: (2013-12-01) -
Opportunities of Neurometabolic Therapy in the Treatment of Neurological Complications of Diabetes Mellitus
by: I.V. Pankiv
Published: (2013-04-01) -
КОГНИТИВНЫЕ НАРУШЕНИЯ ПРИ САХАРНОМ ДИАБЕТЕ У ЛИЦ ПОЖИЛОГО ВОЗРАСТА
by: А. А. Фирсов, et al.
Published: (2014-08-01)